{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:56:21Z","timestamp":1789790181266,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T00:00:00Z","timestamp":1460678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s10689-016-9901-9","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T10:29:04Z","timestamp":1460716144000},"page":"467-475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Chemoprevention of familial adenomatous polyposis"],"prefix":"10.1007","volume":"15","author":[{"given":"Patrick M.","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,15]]},"reference":[{"key":"9901_CR1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.soc.2015.06.006","volume":"24","author":"K Jasperson","year":"2015","unstructured":"Jasperson K, Burt RW (2015) The genetics of colorectal cancer. Surg Oncol Clin N Am 24:683\u2013703","journal-title":"Surg Oncol Clin N Am"},{"key":"9901_CR2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/14656560802560153","volume":"10","author":"E Half","year":"2009","unstructured":"Half E, Arber N (2009) Colon cancer: preventive agents and the present status of chemoprevention. Expert Opin Pharmacother 10:211\u2013219","journal-title":"Expert Opin Pharmacother"},{"key":"9901_CR3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bpg.2011.08.002","volume":"25","author":"B Kim","year":"2011","unstructured":"Kim B, Giardiello FM (2011) Chemoprevention in familial adenomatous polyposis. Best Pract Res Clin Gastroenterol 25:607\u2013622","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"9901_CR4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jso.2930240119","volume":"24","author":"WR Waddell","year":"1983","unstructured":"Waddell WR, Loughry RW (1983) Sulindac for polyposis of the colon. J Surg Oncol 24:83\u201387","journal-title":"J Surg Oncol"},{"key":"9901_CR5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0016-5085(91)90519-Q","volume":"101","author":"D Labayle","year":"1991","unstructured":"Labayle D et al (1991) Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101:635\u2013639","journal-title":"Gastroenterology"},{"key":"9901_CR6","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","volume":"328","author":"FM Giardiello","year":"1993","unstructured":"Giardiello FM et al (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313\u20131316","journal-title":"N Engl J Med"},{"key":"9901_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00341270","volume":"8","author":"G Winde","year":"1993","unstructured":"Winde G, Gumbinger HG, Osswald H, Kemper F, Bunte H (1993) The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration. Int J Colorectal Dis 8:13\u201317","journal-title":"Int J Colorectal Dis"},{"key":"9901_CR8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1053\/gast.2002.31890","volume":"122","author":"M Cruz-Correa","year":"2002","unstructured":"Cruz-Correa M, Hylind LM, Romans KE, Booker SV, Giardiello FM (2002) Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 122:641\u2013645","journal-title":"Gastroenterology"},{"key":"9901_CR9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(95)92989-4","volume":"345","author":"HS Debinski","year":"1995","unstructured":"Debinski HS, Trojan J, Nugent KP, Spigelman AD, Phillips RK (1995) Effect of sulindac on small polyps in familial adenomatous polyposis. Lancet 345:855\u2013856","journal-title":"Lancet"},{"key":"9901_CR10","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/bjs.1800801244","volume":"80","author":"KP Nugent","year":"1993","unstructured":"Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK (1993) Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 80:1618\u20131619","journal-title":"Br J Surg"},{"key":"9901_CR11","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/bjs.1800831232","volume":"83","author":"F Seow-Choen","year":"1996","unstructured":"Seow-Choen F, Vijayan V, Keng V (1996) Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis. Br J Surg 83:1763\u20131766","journal-title":"Br J Surg"},{"key":"9901_CR12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gut.2003.027771","volume":"53","author":"S Bulow","year":"2004","unstructured":"Bulow S et al (2004) Duodenal adenomatosis in familial adenomatous polyposis. Gut 53:381\u2013386","journal-title":"Gut"},{"key":"9901_CR13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","volume":"352","author":"SD Solomon","year":"2005","unstructured":"Solomon SD et al (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352:1071\u20131080","journal-title":"N Engl J Med"},{"key":"9901_CR14","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","volume":"352","author":"RS Bresalier","year":"2005","unstructured":"Bresalier RS et al (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092\u20131102","journal-title":"N Engl J Med"},{"key":"9901_CR15","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","volume":"342","author":"G Steinbach","year":"2000","unstructured":"Steinbach G et al (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946\u20131952","journal-title":"N Engl J Med"},{"key":"9901_CR16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/gut.50.6.857","volume":"50","author":"RK Phillips","year":"2002","unstructured":"Phillips RK et al (2002) A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 50:857\u2013860","journal-title":"Gut"},{"key":"9901_CR17","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1023\/A:1026130623186","volume":"48","author":"A Hallak","year":"2003","unstructured":"Hallak A et al (2003) Rofecoxib reduces polyp recurrence in familial polyposis. Dig Dis Sci 48:1998\u20132002","journal-title":"Dig Dis Sci"},{"key":"9901_CR18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/1940-6207.CAPR-11-0106","volume":"4","author":"J Burn","year":"2011","unstructured":"Burn J et al (2011) A randomized placebo-controlled prevention trial of aspirin and\/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res (Phila) 4:655\u2013665","journal-title":"Cancer Prev Res (Phila)"},{"key":"9901_CR19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cam4.46","volume":"2","author":"H Ishikawa","year":"2013","unstructured":"Ishikawa H et al (2013) Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial. Cancer Med 2:50\u201356","journal-title":"Cancer Med"},{"key":"9901_CR20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1158\/1078-0432.CCR-08-2235","volume":"15","author":"EW Gerner","year":"2009","unstructured":"Gerner EW, Meyskens FL Jr (2009) Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation. Clin Cancer Res 15:758\u2013761","journal-title":"Clin Cancer Res"},{"key":"9901_CR21","first-page":"945","volume":"5","author":"FL Meyskens Jr","year":"1999","unstructured":"Meyskens FL Jr, Gerner EW (1999) Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin Cancer Res 5:945\u2013951","journal-title":"Clin Cancer Res"},{"key":"9901_CR22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/gutjnl-2014-307235","volume":"65","author":"PM Lynch","year":"2016","unstructured":"Lynch PM et al (2016) An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis. Gut 65:286\u2013295","journal-title":"Gut"},{"key":"9901_CR23","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cgh.2006.03.020","volume":"4","author":"M Cruz-Correa","year":"2006","unstructured":"Cruz-Correa M et al (2006) Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 4:1035\u20131038","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9901_CR24","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/1097-0142(19821001)50:7<1434::AID-CNCR2820500733>3.0.CO;2-F","volume":"50","author":"HJ Bussey","year":"1982","unstructured":"Bussey HJ et al (1982) A randomized trial of ascorbic acid in polyposis coli. Cancer 50:1434\u20131439","journal-title":"Cancer"},{"key":"9901_CR25","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/gut.2009.200642","volume":"59","author":"NJ West","year":"2010","unstructured":"West NJ et al (2010) Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut 59:918\u2013925","journal-title":"Gut"},{"key":"9901_CR26","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMoa012015","volume":"346","author":"FM Giardiello","year":"2002","unstructured":"Giardiello FM et al (2002) Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med 346:1054\u20131059","journal-title":"N Engl J Med"},{"key":"9901_CR27","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/ajg.2009.758","volume":"105","author":"PM Lynch","year":"2010","unstructured":"Lynch PM et al (2010) The safety and efficacy of celecoxib in children with familial adenomatous polyposis. Am J Gastroenterol 105:1437\u20131443","journal-title":"Am J Gastroenterol"},{"key":"9901_CR28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.gie.2012.11.038","volume":"77","author":"PM Lynch","year":"2013","unstructured":"Lynch PM et al (2013) Global quantitative assessment of the colorectal polyp burden in familial adenomatous polyposis by using a web-based tool. Gastrointest Endosc 77:455\u2013463","journal-title":"Gastrointest Endosc"},{"key":"9901_CR29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(89)90840-4","volume":"2","author":"AD Spigelman","year":"1989","unstructured":"Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK (1989) Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 2:783\u2013785","journal-title":"Lancet"},{"key":"9901_CR30","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.acra.2006.03.018","volume":"13","author":"S Taylor","year":"2006","unstructured":"Taylor S, Slater A, Honeyfield L, Burling D, Halligan S (2006) CT colonography: effect of colonic distension on polyp measurement accuracy and agreement-in vitro study. Acad Radiol 13:850\u2013859","journal-title":"Acad Radiol"},{"key":"9901_CR31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2214\/ajr.173.1.10397149","volume":"173","author":"M Macari","year":"1999","unstructured":"Macari M, Green JC, Berman P, Milano A (1999) Diagnosis of familial adenomatous polyposis using two-dimensional and three-dimensional CT colonography. AJR Am J Roentgenol 173:249\u2013250","journal-title":"AJR Am J Roentgenol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-016-9901-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-016-9901-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-016-9901-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:46:19Z","timestamp":1559252779000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-016-9901-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,15]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["9901"],"URL":"https:\/\/doi.org\/10.1007\/s10689-016-9901-9","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,15]]}}}